BioCatalyst

Kedrion IVIG 10% — catalyst calendar

2 verified catalyst event(s) referencing Kedrion IVIG 10%, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 4mo
ESTIMATED
 READOUT
Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Ped
Phase 3 · Primary Immunodeficiency Disease
 Kedrion S.p.A. Kedrion IVIG 10% ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
2026-12 (month)
in 4mo
ESTIMATED
 READOUT
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With
Phase 3 · Chronic Primary Immune Thrombocytopenia (ITP)
 Kedrion S.p.A. Kedrion IVIG 10% ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.